Multiple Insiders Have Bought Valeant and These Healthcare Stocks

Page 1 of 2

Stocks bought by insiders tend to outperform the market, and the effect is particularly strong when multiple insiders are buying (learn more about studies on insider trading). We think that this is because insider purchases signal that these individuals are very confident in the stock’s prospects- so confident that they buy when economic theory suggests they should be trying to sell and therefore reduce their exposure to any particular company. It makes sense that when more than one insider comes to this conclusion that confidence has to be particularly high- though of course even in this case it’s important to study the company to make sure that it might actually be a good value. Here are four healthcare stocks that multiple insiders have bought shares of within the last three months:

Synageva Biopharma Corp (NASDAQ:GEVA), a development stage pharmaceutical company, has been one such target of insider purchases in the healthcare sector. Synageva is developing a drug designed to treat lysosomal acid lipase deficiency as well as other products aimed at rare diseases and medical conditions. As a development stage company, it is currently unprofitable and its net losses are actually expected to grow in 2013 as well. That makes it a bit speculative of an investment for us, particularly as we have no understanding of Synageva’s products. Baker Brothers Advisors, a healthcare focused fund which is managed by Felix and Julian Baker, reported a position of 8.4 million shares at the end of Q3 2012. This made it one of the five largest holdings in Baker Brothers’ portfolio (find more of its favorite stocks).

VALUEACT CAPITAL

Another healthcare stock that multiple insiders have been buying is Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The $20 billion market cap pharmaceutical company was one of the top picks in the portfolio of Jeffrey Ubben’s ValueAct Capital (see more stocks Ubben likes) and Tiger Cub Andreas Halvorsen’s Viking Global reported a large position as well (research more stocks Halvorsen owns). While Valeant’s revenue numbers have been looking good, earnings have been down. Value investors might be more comfortable looking at Teva Pharmaceutical Industries Ltd (NYSE:TEVA), which carries trailing and 2013 P/E multiples of 15 and 7 respectively. Still, the optimism from two company officers and one member of Valeant’s Board of Directors might make the company worth at least some investigation into whether it can stabilize and grow its business.

Two medical device companies completed our list:

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

On the Move: The 10 Fastest Growing Businesses in 2015

Fast Money: The 10 Highest Paying Fast Food Restaurants

Mixing It Up: The 14 Best Music Mashups of 2014

Rito Pls Buff: The 10 Least Played Champions in LoL Season 4

10 Covers of Popular Songs that are Better than the Originals

Must See TV: The 9 Most Anticipated Shows of 2015

The 15 Biggest Box Office Bombs of All Time

10 Things The World Can’t Stand About Americans

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!